With over 10 million people affected worldwide, Parkinson's disease is the fastest-growing neurological disorder. More than ...

Region Genetic Association Analysis of Breast Cancer Patients With and Without Persistent Postsurgical Neuropathic Pain,” ...

Incyte Announces Positive Topline Results From Two Phase 3 Clinical Trials of Povorcitinib in Patients with Hidradenitis ...

Incyte Corporation (NASDAQ:INCY) released topline results from its pivotal Phase 3 STOP-HS clinical trial program of ...

Povorcitinib is an oral Janus kinase 1 selective inhibitor that works to reduce the overactive inflammatory signaling pathway seen in HS.

3-point decrease in the Skin Pain Numeric Rating Scale (NRS) score and Skin Pain NRS30. Furthermore, povorcitinib demonstrated rapid onset of response, including rapid skin pain reduction.

Tris' drug outperformed placebo on the main efficacy measure in the study – the pain numerical rate scale (NRS) area under the curve from four through 48 hours (AUC4-48) – which gives a ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Objective: To develop and test the reliability and validity of the State Behavioral Scale for use in describing ... and a numeric rating scale (NRS) of 0 (extremely sedated) to 10 (extremely ...